M. A. Ucar Et Al. , "Real world results of venetoclax combined with hypomethylating agents in relapsed/refractory AML.," European review for medical and pharmacological sciences , vol.25, no.21, pp.6557-6565, 2021
Ucar, M. A. Et Al. 2021. Real world results of venetoclax combined with hypomethylating agents in relapsed/refractory AML.. European review for medical and pharmacological sciences , vol.25, no.21 , 6557-6565.
Ucar, M. A., Ozet, G., Koyuncu, M. B., Sonmez, M., Akidan, O., Ayli, M., ... Yildirim, M.(2021). Real world results of venetoclax combined with hypomethylating agents in relapsed/refractory AML.. European review for medical and pharmacological sciences , vol.25, no.21, 6557-6565.
Ucar, M Et Al. "Real world results of venetoclax combined with hypomethylating agents in relapsed/refractory AML.," European review for medical and pharmacological sciences , vol.25, no.21, 6557-6565, 2021
Ucar, M A. Et Al. "Real world results of venetoclax combined with hypomethylating agents in relapsed/refractory AML.." European review for medical and pharmacological sciences , vol.25, no.21, pp.6557-6565, 2021
Ucar, M. A. Et Al. (2021) . "Real world results of venetoclax combined with hypomethylating agents in relapsed/refractory AML.." European review for medical and pharmacological sciences , vol.25, no.21, pp.6557-6565.
@article{article, author={M A Ucar Et Al. }, title={Real world results of venetoclax combined with hypomethylating agents in relapsed/refractory AML.}, journal={European review for medical and pharmacological sciences}, year=2021, pages={6557-6565} }